HAMINSULIN 30/70 CARTIGE 1VAIL

About

Haminsulin 30/70 Cartridge 1Vial contains biphasic human insulin 30/70, a premixed insulin formulation. This product consists of 30% soluble human insulin and 70% isophane human insulin (NPH). It is indicated for the treatment of diabetes mellitus in patients who require both mealtime and basal insulin for glycemic control. The soluble human insulin component provides a relatively rapid onset of action to cover mealtime glucose needs, while the isophane human insulin component offers a prolonged duration of action, addressing basal insulin requirements throughout the day. This combination allows for a simplified insulin regimen, often requiring fewer daily injections compared to separate rapid and intermediate-acting insulin regimens, which can enhance patient convenience and adherence. The vial format allows for flexible dosing and is typically administered via a syringe. Regular monitoring of blood glucose levels is crucial to optimize dosing and achieve target glycemic goals, minimizing the risk of both hyperglycemia and hypoglycemia.

Uses

• Treatment of Type 1 diabetes mellitus
• Treatment of Type 2 diabetes mellitus
• Provides both mealtime and basal insulin needs
• Comprehensive glycemic control

Directions For Use

Inject subcutaneously 30 minutes before a meal. Rotate injection sites to prevent lipodystrophy.

Benefits

• Combines rapid and intermediate insulin action
• Reduces the total number of daily injections
• Provides sustained glucose lowering throughout the day
• Cost-effective option for insulin therapy
• Offers flexible dosing for patient convenience
• Contributes to overall glycemic stability

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat tissue changes at injection site)
• Weight gain
• Allergic reactions (rash, itching, hives)
• Peripheral edema (swelling of extremities)
• Pruritus (itching)
• Rash
• Urticaria (hives)
• Vision changes (temporary)
• Peripheral neuropathy (nerve damage)
• Hypokalemia (low potassium levels)

Safety Measures

• Alcohol - Alcohol consumption can lower blood sugar and increase the risk of hypoglycemia. Use with caution and monitor blood glucose levels closely.
• Pregnancy - Consult a doctor. Insulin requirements may change significantly during pregnancy. Close monitoring and dose adjustments are essential.
• Breastfeeding - Generally considered safe, but monitor the infant for signs of hypoglycemia. Discuss with your healthcare provider.
• Liver - Use with caution in patients with liver impairment. Dose adjustments may be necessary due to altered insulin metabolism.
• Kidney - Use with caution in patients with kidney impairment. Dose adjustments may be necessary due to reduced insulin clearance.
• Lung - No specific direct impact on lung function. Always inform your doctor about any pre-existing lung conditions or respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.